Current Research - Addiction

EEG Ethanol & sLORETA Proprietary Voxel BioMarkers

image128

Our case studies are intensive, systematic investigations, conducted for a single individual, group, or another unit in which SPESA and its collaborators' examine in-depth data relating to several addictions. We systematically examine complex phenomena of addiction in a natural setting to increase the understanding of addictive cravings and prevention of relapse.

(ROI) Voxel-Based BioMarkers & sLORETA Treatment Protocols

image129

The underpinnings of the SPESA Model are previously identified voxel-based biomarkers with treatment protocols diverse from the conventional neurofeedback entrainment (which train to a normalized Z-score). Herein, SPESA’s proprietary sLORETA protocols are targeted to specific clusters of voxels (ROIs). Each treatment session is analyzed using the proprietary learning curve protocols in order to observe operant learning. 

Opiates Relapse BioMarkers & sLORETA Treatment Protocols

image130

SPESA's previously identified voxel-based biomarkers are now being applied in the current SUD research. The corresponding SPESA’s proprietary sLORETA voxel basedprotocols have shown preliminary efficacy among individuals dealing with opiate addiction in particular. In our research, the current subject populations have ranged from the age of 2 years to adults and the treatment sessions were analyzed using proprietary learning curve protocols to observe operant learning.

Recent Case Study Published (3-year-old female with intrautrine drug exposure)